Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Suzette Delaloge"'
Autor:
Isabelle Miran, Dominique Scherer, Pauline Ostyn, Chafika Mazouni, Françoise Drusch, Marine Bernard, Emilie Louvet, Julien Adam, Marie-Christine Mathieu, Mariam Haffa, Jean-Philippe Antignac, Bruno Le Bizec, Philippe Vielh, Philippe Dessen, Hervé Perdry, Suzette Delaloge, Jean Feunteun
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Frontiers, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Frontiers, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
International audience; The tissue stroma plays a major role in tumors' natural history. Most programs for tumor progression are not activated as cell-autonomous processes but under the conditions of cross-talks between tumor and stroma. Adipose tiss
Autor:
Jacqueline Deneuve, Audrey Poterie, Stefan Michiels, Sandy Azoulay, Marie-Christine Mathieu, Alexander Valent, Voichita Suciu, Ludovic Lacroix, Monica Arnedos, Suzette Delaloge, Isabelle Miran, Philippe Vielh, Claudia Rodriguez, Amelie Boichard
Publikováno v:
Molecular Oncology. 10:1430-1436
Determining the status of HER2-neu amplification and overexpression in breast cancer is crucial for prognosis but mostly for treatment purposes. Standard techniques include the determination of IHC in combination with in situ hybridization techniques
Publikováno v:
European journal of cancer care. 26(6)
Although a cure still cannot be expected for metastatic breast cancer, thanks to progressive advances in treatments, life expectancy has been increasing over the past 15 years. This study aims to present the impact on the organisation of patients’
Autor:
J. Cyrta, M. C. Mathieu, Suzette Delaloge, C. Balleyguier, C. Bourgier, C. Mazouni, S. Azoulay, Felipe Andreiuolo, Philippe Vielh
Publikováno v:
Cytopathology. 24:377-384
J. Cyrta, F. Andreiuolo, S. Azoulay, C. Balleyguier, C. Bourgier, C. Mazouni, M.-C. Mathieu, S. Delaloge and P. Vielh Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature Objective: Mu
Autor:
Laura Senovilla, Marie Laure Poillot, Guido Kroemer, Marie Chaix, Patrick Arveux, Fabrice Andre, Laurent Arnould, Vichnou Poirier-Colame, Laurence Zitvogel, Sylvain Ladoire, David Enot, Suzette Delaloge, François Ghiringhelli, Frédérique Penault-Llorca, Kariman Chaba, Michaela Semeraro
Publikováno v:
Autophagy
Autophagy, 2016, 12 (5), pp.864-875. ⟨10.1080/15548627.2016.1154244⟩
Autophagy, Taylor & Francis, 2016, 12 (5), pp.864-875. ⟨10.1080/15548627.2016.1154244⟩
Autophagy, Taylor & Francis, 2016, 12 (5), pp.864-875. 〈http://www.tandfonline.com/doi/abs/10.1080/15548627.2016.1154244?journalCode=kaup20〉. 〈10.1080/15548627.2016.1154244〉
Autophagy, 2016, 12 (5), pp.864-875. ⟨10.1080/15548627.2016.1154244⟩
Autophagy, Taylor & Francis, 2016, 12 (5), pp.864-875. ⟨10.1080/15548627.2016.1154244⟩
Autophagy, Taylor & Francis, 2016, 12 (5), pp.864-875. 〈http://www.tandfonline.com/doi/abs/10.1080/15548627.2016.1154244?journalCode=kaup20〉. 〈10.1080/15548627.2016.1154244〉
International audience; Several cell-intrinsic alterations have poor prognostic features in human breast cancer, as exemplified by the absence of MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 )-positive puncta in the cytoplasm (which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c9506f953729bb5592c58d37f24f38
https://hal.science/hal-01428960
https://hal.science/hal-01428960
Autor:
Cecile Vicier, M. C. Mathieu, Suzette Delaloge, Françoise Drusch, Olivia Fromigué, Véronique Scott, Veronika Smutná, Pierfranco Conte, Ludovic Lacroix, Guangliang Yin, Mélanie Laporte, Ran Xu, Philippe Vielh, Fabrice Andre, Maria Vittoria Dieci, Celine Lefebvre, Valentina Guarneri
Publikováno v:
Breast cancer research and treatment. 156(1)
Little is known about mutational landscape of rare breast cancer (BC) subtypes. The aim of the study was to apply next generation sequencing to three different subtypes of rare BCs in order to identify new genes related to cancer progression. We perf
Autor:
Jean Selleslags, Françoise Lallemand, Martine Piccart-Gebhart, Birgit Carly, A. Vindevoghel, Roberto Salgado, Virginie Durbecq, Fatima Cardoso, Christos Sotiriou, Fraser Symmans, Lajos Pusztai, Yuan Qi, Denis Larsimont, Gianluca Bontempi, Benjamin Haibe-Kains, Evandro de Azambuja, Suzette Delaloge, Stefan Michiels, Marie Maerevoet, Ghizlane Rouas, Marc Buyse, Rodrigo Kraft Rovere, Angelo Di Leo, Jean-Pierre Kains, Christine Desmedt, Véronique D'Hondt, Jean-Marie Nogaret, C. Duhem
Publikováno v:
Journal of Clinical Oncology. 29:1578-1586
Purpose Validated biomarkers predictive of response/resistance to anthracyclines in breast cancer are currently lacking. The neoadjuvant Trial of Principle (TOP) study, in which patients with estrogen receptor (ER) –negative tumors were treated wit
Autor:
Christophe M. Raynaud, Frédéric Commo, Paolo Nuciforo, Juana Hernandez, M. C. Mathieu, Frédérique P. Llorca, Suzette Delaloge, Jean-Charles Soria, Fabrice Andre, Laure Sabatier
Publikováno v:
American Journal of Clinical Oncology. 33:341-345
OBJECTIVES: Carcinogenesis is a multistep process involving the accumulation of genetic and molecular abnormalities. It has been suggested that there is a relationship between telomere attrition in the early stages of carcinogenesis and activation of
Autor:
Corinne Balleyguier, Philippe Vielh, Elie Azria, Suzette Delaloge, Catherine Uzan, Voichita Suciu, Véronique Scott, Fabrice Andre, Ludovic Lacroix, Isabelle Laurent
Publikováno v:
Cancer Cytopathology. 117:32-39
BACKGROUND: With the widespread development of genomic analysis, an accurate and quick method for obtaining high-quality nucleic acids is needed. The objective of the current study was to evaluate the quality and potential use of material obtained fr
Autor:
Maryam Mehrpour, Salem Chouaib, J. Grassi, N. Morel, Franck Meslin, M-C Mathieu, Rosa Conforti, Suzette Delaloge, Fabrice Andre, G. Tomasic, Françoise Drusch, M. Yacoub, Chafika Mazouni, Jean-Christophe Sabourin
Publikováno v:
Annals of Oncology. 18:1793-1798
Background: Prion protein (PrPc) has been previously reported to be associated with resistance to proapoptotic stimuli. We evaluated whether the expression of PrPc was associated with the resistance to adjuvant chemotherapy in patients with estrogen